Lista de obras - Sui Shen - Dominio Público Uruguay

A dynamic supraclavicular field-matching technique for head-and-neck cancer patients treated with IMRT.

artículo científico publicado en 2004

A method to correct for radioactivity in large vessels that overlap the spine in imaging-based marrow dosimetry of lumbar vertebrae

artículo científico publicado en 2008

A novel monoclonal antibody design for radioimmunotherapy

artículo científico publicado en 2003

A preliminary cell kinetics model of thrombocytopenia after radioimmunotherapy ⬇️

artículo científico publicado el 1 de julio de 1998

A technique using 99mTc-mebrofenin SPECT for radiotherapy treatment planning for liver cancers or metastases

artículo científico publicado en 2013

Are Radiometal-Labeled Antibodies Better Than Iodine-131–Labeled Antibodies: Comparative Pharmacokinetics and Dosimetry of Copper-67–, Iodine-131–, and Yttrium-90–Labeled Lym-1 Antibody in Patients with Non-Hodgkin's Lymphoma ⬇️

artículo científico publicado el 1 de septiembre de 2000

Assaying 192Ir line sources using a standard length well chamber

artículo científico publicado en 2002

Attenuation of intracavitary applicators in 192Ir-HDR brachytherapy

artículo científico publicado en 2004

Biodistribution and dosimetry of In-111/Y-90-HuCC49ΔCh2 (IDEC-159) in patients with metastatic colorectal adenocarcinoma

artículo científico publicado en 2011

Clinically useful marrow dosimetry for targeted radionuclide therapy

artículo científico publicado en 2005

Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenografts ⬇️

artículo científico publicado el 1 de octubre de 1998

Comparison of biodistribution, dosimetry, and outcome from clinical trials of radionuclide-CC49 antibody therapy.

artículo científico publicado en 2003

Comparison of methods for predicting myelotoxicity for non-marrow targeting I-131-antibody therapy

scientific article published on 01 April 2003

Comparison of normal tissue pharmacokinetics with 111In/90Y monoclonal antibody m170 for breast and prostate cancer.

artículo científico publicado en 2006

Comprehensive evaluation of a commercial macro Monte Carlo electron dose calculation implementation using a standard verification data set.

artículo científico publicado en 2006

Conventional high-dose-rate brachytherapy with concomitant complementary IMRT boost: a novel approach for improving cervical tumor dose coverage

artículo científico publicado en 2007

Custom step wedge blocking using dynamic multileaf collimation for parametrial pelvic boost irradiation following brachytherapy for carcinoma of the cervix

artículo científico publicado en 2003

Development of an accelerated GVF semi-automatic contouring algorithm for radiotherapy treatment planning

artículo científico publicado en 2009

Dose errors due to inhomogeneities in balloon catheter brachytherapy for breast cancer

artículo científico publicado en 2004

Dose escalation and dosimetry of first-in-human α radioimmunotherapy with 212Pb-TCMC-trastuzumab.

artículo científico publicado en 2014

Dosimetric and radiobiological impact of dose fractionation on respiratory motion induced IMRT delivery errors: a volumetric dose measurement study

artículo científico publicado en 2006

Dosimetric effect of respiration-gated beam on IMRT delivery

artículo científico publicado en 2003

Dosimetry for radioimmunotherapy: a rapidly evolving field

scientific article published on 01 April 1999

Effects of bladder distension on organs at risk in 3D image-based planning of intracavitary brachytherapy for cervical cancer

artículo científico publicado en 2009

End-to-end test of spatial accuracy in Gamma Knife treatments for trigeminal neuralgia

artículo científico publicado en 2014

Enhancement of 67Cu‐2IT‐BAT‐LYM‐1 therapy in mice with human burkitt's lymphoma (Raji) using interleukin‐2 ⬇️

artículo científico publicado el 15 de diciembre de 1997

High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent

scientific article published on 01 August 2005

ING-1, a monoclonal antibody targeting Ep-CAM in patients with advanced adenocarcinomas

scientific article published on 01 November 2004

Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk

artículo científico publicado en 2011

Image-based three-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: dose-volume histograms of the bladder, rectum, sigmoid colon, and small bowel

artículo científico publicado en 2007

Imaging for improved prediction of myelotoxicity after radioimmunotherapy ⬇️

artículo científico publicado el 15 de diciembre de 1997

Impact of interpatient pharmacokinetic variability on design considerations for therapy with radiolabeled MAbs

artículo científico publicado en 2003

Impact of splenomegaly on therapeutic response and I‐131‐LYM‐1 dosimetry in patients with B‐lymphocytic malignancies ⬇️

artículo científico publicado el 15 de diciembre de 1997

Intensity modulation with respiratory gating for radiotherapy of the pleural space.

artículo científico publicado en 2007

Intraoperative ultrasound guidance during intracavitary brachytherapy applicator placement in cervical cancer: the University of Alabama at Birmingham experience

artículo científico publicado en 2013

Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region.

artículo científico publicado en 2005

Low-dose, fractionated radioimmunotherapy for B-cell malignancies using 131I-Lym-1 antibody.

artículo científico publicado en 1998

MIRD dose estimate report No. 20: radiation absorbed-dose estimates for 111In- and 90Y-ibritumomab tiuxetan.

artículo científico publicado en 2009

Maximum tolerated dose of 67Cu-2IT-BAT-LYM-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: a pilot study

artículo científico publicado el 1 de julio de 1998

Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma

artículo científico publicado en 1998

Molecular imaging of prostate cancer targeting CD46 using immunoPET

scientific article published on 08 December 2020

Pharmacokinetics and imaging of 212Pb-TCMC-trastuzumab after intraperitoneal administration in ovarian cancer patients

artículo científico publicado en 2013

Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma

artículo científico publicado en 2004

Phase I study of 90Y-CC49 monoclonal antibody therapy in patients with advanced non-small cell lung cancer: effect of chelating agents and paclitaxel co-administration

artículo científico publicado en 2005

Phase I study of a modified regimen of ⁹⁰Yttrium-ibritumomab tiuxetan for relapsed or refractory follicular or transformed CD20+ non-Hodgkin lymphoma

artículo científico publicado en 2013

Practical determination of organ S values for individual patients for therapy ⬇️

artículo científico publicado el 1 de julio de 1997

Prediction of myelotoxicity using radiation doses to marrow from body, blood and marrow sources ⬇️

artículo científico publicado el 1 de septiembre de 1997

Prolonged survival associated with immune response in a patient treated with Lym-1 mouse monoclonal antibody.

artículo científico publicado en 1998

Quantification of iodine-131 in tumors using a threshold based on image contrast ⬇️

artículo científico publicado el 1 de mayo de 1998

Radiation dosimetry of 131I-chlorotoxin for targeted radiotherapy in glioma-bearing mice

artículo científico publicado en 2005

Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: results of a phase I clinical trial ⬇️

artículo científico publicado el 1 de agosto de 1997

Radioimmunotherapy of acquired immunodeficiency syndrome (AIDS) associated lymphoma.

artículo científico publicado en 1999

Retreatment with yttrium-90 ibritumomab tiuxetan in patients with B-cell non-Hodgkin's lymphoma

artículo científico publicado en 2007

Splenic volume change and nodal tumor response in non-Hodgkin's lymphoma patients after radioimmunotherapy using radiolabeled Lym-1 antibody

artículo científico publicado en 2005

Testicular uptake and radiation dose in patients receiving Zevalin and Pretarget CC49Fusion protein

artículo científico publicado en 2005

The use of endoscopic ultrasound-guided gold markers in image-guided radiation therapy of pancreatic cancers: a case series

artículo científico publicado en 2010

Validation of target volume and position in respiratory gated CT planning and treatment.

artículo científico publicado en 2003

Yttrium-90-DOTA-peptide-chimeric L6 radioimmunoconjugate: efficacy and toxicity in mice bearing p53 mutant human breast cancer xenografts ⬇️

artículo científico publicado el 1 de mayo de 1998

Lista de obras de Sui Shen

A dynamic supraclavicular field-matching technique for head-and-neck cancer patients treated with IMRT.

A method to correct for radioactivity in large vessels that overlap the spine in imaging-based marrow dosimetry of lumbar vertebrae

A novel monoclonal antibody design for radioimmunotherapy

A preliminary cell kinetics model of thrombocytopenia after radioimmunotherapy ⬇️

A technique using 99mTc-mebrofenin SPECT for radiotherapy treatment planning for liver cancers or metastases

Are Radiometal-Labeled Antibodies Better Than Iodine-131–Labeled Antibodies: Comparative Pharmacokinetics and Dosimetry of Copper-67–, Iodine-131–, and Yttrium-90–Labeled Lym-1 Antibody in Patients with Non-Hodgkin's Lymphoma ⬇️

Assaying 192Ir line sources using a standard length well chamber

Attenuation of intracavitary applicators in 192Ir-HDR brachytherapy

Biodistribution and dosimetry of In-111/Y-90-HuCC49ΔCh2 (IDEC-159) in patients with metastatic colorectal adenocarcinoma

Clinically useful marrow dosimetry for targeted radionuclide therapy

Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenografts ⬇️

Comparison of biodistribution, dosimetry, and outcome from clinical trials of radionuclide-CC49 antibody therapy.

Comparison of methods for predicting myelotoxicity for non-marrow targeting I-131-antibody therapy

Comparison of normal tissue pharmacokinetics with 111In/90Y monoclonal antibody m170 for breast and prostate cancer.

Comprehensive evaluation of a commercial macro Monte Carlo electron dose calculation implementation using a standard verification data set.

Conventional high-dose-rate brachytherapy with concomitant complementary IMRT boost: a novel approach for improving cervical tumor dose coverage

Custom step wedge blocking using dynamic multileaf collimation for parametrial pelvic boost irradiation following brachytherapy for carcinoma of the cervix

Development of an accelerated GVF semi-automatic contouring algorithm for radiotherapy treatment planning

Dose errors due to inhomogeneities in balloon catheter brachytherapy for breast cancer

Dose escalation and dosimetry of first-in-human α radioimmunotherapy with 212Pb-TCMC-trastuzumab.

Dosimetric and radiobiological impact of dose fractionation on respiratory motion induced IMRT delivery errors: a volumetric dose measurement study

Dosimetric effect of respiration-gated beam on IMRT delivery

Dosimetry for radioimmunotherapy: a rapidly evolving field

Effects of bladder distension on organs at risk in 3D image-based planning of intracavitary brachytherapy for cervical cancer

End-to-end test of spatial accuracy in Gamma Knife treatments for trigeminal neuralgia

Enhancement of 67Cu‐2IT‐BAT‐LYM‐1 therapy in mice with human burkitt's lymphoma (Raji) using interleukin‐2 ⬇️

High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent

ING-1, a monoclonal antibody targeting Ep-CAM in patients with advanced adenocarcinomas

Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk

Image-based three-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: dose-volume histograms of the bladder, rectum, sigmoid colon, and small bowel

Imaging for improved prediction of myelotoxicity after radioimmunotherapy ⬇️

Impact of interpatient pharmacokinetic variability on design considerations for therapy with radiolabeled MAbs

Impact of splenomegaly on therapeutic response and I‐131‐LYM‐1 dosimetry in patients with B‐lymphocytic malignancies ⬇️

Intensity modulation with respiratory gating for radiotherapy of the pleural space.

Intraoperative ultrasound guidance during intracavitary brachytherapy applicator placement in cervical cancer: the University of Alabama at Birmingham experience

Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region.

Low-dose, fractionated radioimmunotherapy for B-cell malignancies using 131I-Lym-1 antibody.

MIRD dose estimate report No. 20: radiation absorbed-dose estimates for 111In- and 90Y-ibritumomab tiuxetan.

Maximum tolerated dose of 67Cu-2IT-BAT-LYM-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: a pilot study

Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma

Molecular imaging of prostate cancer targeting CD46 using immunoPET

Pharmacokinetics and imaging of 212Pb-TCMC-trastuzumab after intraperitoneal administration in ovarian cancer patients

Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma

Phase I study of 90Y-CC49 monoclonal antibody therapy in patients with advanced non-small cell lung cancer: effect of chelating agents and paclitaxel co-administration

Phase I study of a modified regimen of ⁹⁰Yttrium-ibritumomab tiuxetan for relapsed or refractory follicular or transformed CD20+ non-Hodgkin lymphoma

Practical determination of organ S values for individual patients for therapy ⬇️

Prediction of myelotoxicity using radiation doses to marrow from body, blood and marrow sources ⬇️

Prolonged survival associated with immune response in a patient treated with Lym-1 mouse monoclonal antibody.

Quantification of iodine-131 in tumors using a threshold based on image contrast ⬇️

Radiation dosimetry of 131I-chlorotoxin for targeted radiotherapy in glioma-bearing mice

Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: results of a phase I clinical trial ⬇️

Radioimmunotherapy of acquired immunodeficiency syndrome (AIDS) associated lymphoma.

Retreatment with yttrium-90 ibritumomab tiuxetan in patients with B-cell non-Hodgkin's lymphoma

Splenic volume change and nodal tumor response in non-Hodgkin's lymphoma patients after radioimmunotherapy using radiolabeled Lym-1 antibody

Testicular uptake and radiation dose in patients receiving Zevalin and Pretarget CC49Fusion protein

The use of endoscopic ultrasound-guided gold markers in image-guided radiation therapy of pancreatic cancers: a case series

Validation of target volume and position in respiratory gated CT planning and treatment.

Yttrium-90-DOTA-peptide-chimeric L6 radioimmunoconjugate: efficacy and toxicity in mice bearing p53 mutant human breast cancer xenografts ⬇️